Navigation Links
Depomed Reports Third Quarter Financial Results
Date:11/5/2012

rtization associated with the Zipsor acquisition and one-time research and development expenses of $1.8 million for the NDA filing fee for Serada and $0.6 million for the payment of a license milestone to a licensor of one of the Serada patents. Operating expenses for third quarter 2012 did not reflect any promotion fee expense, compared with $6.0 million in promotion fee expense for third quarter 2011.

Net loss for third quarter 2012 was ($1.5) million, or ($0.03) per share, compared to net loss of ($8.6) million, or ($0.15) per share for third quarter 2011.

Cash, cash equivalents and marketable securities were $87.7 million as of September 30, 2012 compared to $139.8 million as of December 31, 2011. 

Conference Call
Depomed will host a conference call today, Monday, November 5, beginning at 5:00 p.m. EST (2:00 p.m. PST) to discuss its results. Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international).  The conference call will also be available via a live webcast on the investor relations section of Depomed's website at http://www.depomed.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Depomed
Depomed, Inc. is a specialty pharmaceutical company with three approved and marketed products. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN).  Zipsor ® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of mild to moderate acute pain in adults.  Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is commercialized by Santarus, Inc. in the United States. Depomed formulate
'/>"/>

SOURCE Depomed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Depomed To Report Third Quarter Fiscal Year 2012 Financial Results On Monday, November 5, 2012
2. Depomed To Present At UBS Global Life Sciences Conference
3. Depomed To Present At Morgan Stanley 2012 Healthcare Conference
4. Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
5. Depomed To Report Second Quarter Fiscal Year 2012 Financial Results On Thursday, August 2, 2012
6. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
7. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
8. Depomed To Present At Jefferies 2012 Global Health Care Conference
9. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
10. Cambrex Reports Third Quarter 2012 Financial Results
11. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is ... introduction of the first-of-its-kind comic book available in ... has been designed specifically to educate children and their parents ... Canada affecting more than 300,000 Canadians. Eisai is ... care (hhc) , in which the patient is central – ...
(Date:8/21/2014)... CHARLOTTE, N.C. , Aug. 21, 2014 /PRNewswire-iReach/ ... Home Medical Equipment, Inc. for the third straight ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... important treatment option for more vulnerable populations , ... showed that pitavastatin is an effective treatment for the ... safety and tolerability profile to low-dose pravastatin. The ... the XV International Symposium on Atherosclerosis in Boston. , ...
... was found to be prevalent in cancer patients regardless of ... conducted at Cancer Treatment Centers of America ... screening for vitamin D deficiency and aggressive vitamin D repletion ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090612/CTCALOGO ) , ...
Cached Medicine Technology:Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 2Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 3Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients 2
(Date:8/22/2014)... growth factor receptor (EGFR) mutations found in the circulating ... non-small cell lung cancer (NSCLC) patients correlates well with ... EGFR tyrosine kinase inhibitor (TKI) therapy is approved for ... the standard for determining mutation status is with DNA ... or not available. A more abundant and less invasive ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 ... Dr. Sen and Dr. Samantha Pearson to help people ... and avoid corrective vision surgery by instead improving their ... prompting an investigative review. , “There’s a reason ... dollars in revenue each year—it’s because people just assume ...
(Date:8/22/2014)... Chicago, IL (PRWEB) August 22, 2014 ... become a thriving fertility destination, and now offers the ... interdisciplinary team of infertility specialists. The fertility network of ... an overall commitment to world-class reproductive care, female and ... program lives up to the standards so eminently set ...
(Date:8/22/2014)... August 22, 2014 The improved access ... specifically in the developing world, has led to the ... number of deaths due to AIDS globally. However, despite ... number of new patients becoming affected by the virus ... being undertaken by all related organisations and stakeholders, by ...
(Date:8/22/2014)... August 22, 2014. A new study of ... with multiple sclerosis (MS) may be able to ... study was epublished ahead of print on July ... Genova, Hali Griswold, Nancy D. Chiaravalloti & John ... with multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is one,s ...
Breaking Medicine News(10 mins):Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... Reinberg HealthDay Reporter , TUESDAY, Feb. 7 (HealthDay News) ... a new "universal" influenza vaccine: one that might be effective against ... year, as now happens. "Our hope is to develop a ... subtypes so we won,t need to keep making new flu vaccines ...
... Repeat cases of shingles may be more common than suspected, ... people only get shingles once in a lifetime. People ... severe pain. The condition is caused by the herpes zoster ... Minn., analyzed the medical records of nearly 1,700 patients, aged ...
... Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly (STMS) publishing ... 42 new titles to its journals program in 2011, ... collaboration with societies or other organizations. Beginning ... Wiley Online Library, offering the latest, peer-reviewed research in ...
... a new and unusual "app" for the smart phone: tracking air ... and preventive medicine, has received a grant to assess a person,s ... this case, the City of Buffalo. The study is ... Health (NIH). A city,s air pollution varies from downtown ...
... associated with higher risks of obesity, heart disease, diabetes, and ... In a ground-breaking new study published in the Feb. ... from University Hospitals (UH) Case Medical Center and Case Western ... less than six hours of sleep at night had an ...
... Mich. Without fanfare, hundreds of thousands of children ... usually to alleviate recurring infections and obstructive sleep problems. ... to a pathologist, who looks for evidence of more ... common practice may not be cost-effective because those additional ...
Cached Medicine News:Health News:'Universal' Flu Vaccine Shows Promise in Early Trial 2Health News:'Universal' Flu Vaccine Shows Promise in Early Trial 3Health News:Shingles Returns More Often Than Thought 2Health News:Over 40 new titles added to Wiley-Blackwell's journals program in 2011 2Health News:New study to use smart phones to track air pollution exposure 2Health News:Lack of sleep found to be a new risk factor for colon cancer 2Health News:The great tonsil dilemma 2Health News:The great tonsil dilemma 3
Solid 4 mm blades. Locking thumb. Dull finish. Holes in bar decrease weight of speculum....
Open 14 mm blades with 6 mm lifting wings. Dull finish....
Open 10 mm blades. Dull finish....
Open wire style 16 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Medicine Products: